# Chongqing Yaoyanyuan Zhiyao

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/chongqing-yaoyanyuan-zhiyao

- Industry: Pharmaceuticals
- Headquarters: Chongqing, China
- Website: www.cqacpf.com
- Latest round: Series A (Oct 10, 2015)
- Investors on record: 2

## About

Established in 1986 and based in Chongqing, China. Chongqing Yaoyanyuan Zhiyao operates as a pharmaceutical company that focuses on production of Chinese patent medicine. It was recognized as the Natonal High-tech Enterprise. Qichao Gan, the chairman of the Company, is also the general manager of Chongqing Duoputai Pharmaceutical Co.,Ltd. The company became the subsidiary of Jiangsu Zhiyuan Pharmaceutical Co. in 2020. In May 2016, Chongqing Yaoyanyuan Zhiyao closed a series A funding from new investor Chongqing Wanxin Technology.

Chongqing Yaoyanyuan Zhiyao is mainly engaged in the development and production of proprietary Chinese medicines. Its product types can be categorized into hard capsules, tablets, granules, tea, pills. There are 12 existing products, including Torch Flower Root Tablets, Jinze Coronary Heart Capsules, Tianma Pills, Fufang Dingxiang Granules, and Vegetable Bubble Tea. Products can be used in the treatment of autoimmune diseases such as rheumatoid arthritis and lupus erythematosus.

## Funding rounds

- Series A, Oct 10, 2015 — Chongqing Venture Capital, Cqdpt.com

## Investors

- Chongqing Venture Capital (https://capitalatlas.ai/funds/chongqing-venture-capital) — Series A
- Cqdpt.com — Series A